Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Q Su

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancerC L Loprinzi, R M Goldberg, J Q Su, et al.
American Journal of Clinical Oncology|April 1, 1996
Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lungE G Shaw, S Frytak, R T Eagan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancerJ R Jett, A W Maksymiuk, J Q Su, et al.
Cancer|December 1, 1994
Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocolL C Hartmann, J N Ingle, L E Wold, et al.
Cancer|November 11, 1992
A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinomaM H Veeder, J R Jett, J Q Su, et al.
Cancer|May 1, 1993
A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the North Central Cancer Treatment GroupD H Gesme, J R Jett, D D Schreffler, et al.
The Journal of Allergy and Clinical Immunology|July 1, 1997
Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitisT B Casale, I L Bernstein, W W Busse, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 1997
Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic responseL P Boulet, K R Chapman, J Côté, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancerC L Loprinzi, R M Goldberg, J Q Su, et al.
American Journal of Clinical Oncology|April 1, 1996
Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lungE G Shaw, S Frytak, R T Eagan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancerJ R Jett, A W Maksymiuk, J Q Su, et al.
Cancer|December 1, 1994
Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocolL C Hartmann, J N Ingle, L E Wold, et al.
Cancer|November 11, 1992
A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinomaM H Veeder, J R Jett, J Q Su, et al.
Cancer|May 1, 1993
A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the North Central Cancer Treatment GroupD H Gesme, J R Jett, D D Schreffler, et al.
The Journal of Allergy and Clinical Immunology|July 1, 1997
Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitisT B Casale, I L Bernstein, W W Busse, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 1997
Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic responseL P Boulet, K R Chapman, J Côté, et al.
Pageof 4